|
|
Identification |
|
Name |
|
Dacomitinib |
|
Synonyms |
|
PF-00299804-03; (2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]-4-(1-piperidinyl)-2-butenamide |
 |
|
Molecular Structure |
|
![CAS # 1110813-31-4, Dacomitinib, PF-00299804-03, (2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]-4-(1-piperidinyl)-2-butenamide](/structures/1110813-31-4.gif) |
|
|
Molecular Formula |
|
C24H25ClFN5O2 |
|
Molecular Weight |
|
469.94 |
|
CAS Registry Number |
|
1110813-31-4 |
| |
|
Properties |
|
|
Density |
|
1.344 |
| |
|
|
| Market Analysis Reports |
|
|
|
| |
|
|
|
|
